Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Peptides|June 5, 2004
Trefoil factor family (TFF) peptides and cancer progressionShahin Emami, Sylvie Rodrigues, Christelle M Rodrigue, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 12, 2018
SMARCAD1 in Breast Cancer ProgressionKholoud Arafat, Elham Al Kubaisy, Shahrazad Sulaiman, et al.
Plos One|October 10, 2014
Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancerYusra Al Dhaheri, Samir Attoub, Gaber Ramadan, et al.
Toxicology|November 16, 2010
Acute respiratory and systemic toxicity of pulmonary exposure to rutile Fe-doped TiO(2) nanorodsAbderrahim Nemmar, Khaled Melghit, Suhail Al-Salam, et al.
Plos One|November 26, 2025
Correction: Carnosol Induces ROS-Mediated Beclin1-Independent Autophagy and Apoptosis in Triple Negative Breast CancerYusra Al Dhaheri, Samir Attoub, Gaber Ramadan, et al.
Nutrients|July 12, 2020
Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro ModelsVishnu Raj, Balaji Venkataraman, Saeeda Almarzooqi, et al.
Peptides|September 23, 2014
Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1PaIlaria Serra, Mariano A Scorciapino, Giorgia Manzo, et al.
Peptides|September 28, 2017
Peptidomic analysis of skin secretions of the Mexican burrowing toad Rhinophrynus dorsalis (Rhinophrynidae): Insight into the origin of host-defense peptides within the Pipidae and characterization of a proline-arginine-rich peptideJ Michael Conlon, Laure Guilhaudis, Jérôme Leprince, et al.
Molecular Cancer Therapeutics|August 25, 2006
Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenograftsQuang-Dé Nguyen, Sylvie Rodrigues, Christelle M Rodrigue, et al.
Annals of the New York Academy of Sciences|October 8, 2008
Attenuated bacteria as effectors in cancer immunotherapyBasel K Al-Ramadi, Maria J Fernandez-Cabezudo, Hussain El-Hasasna, et al.
Pageof 8